Abstract During cancer evolution, de-repressed repetitive elements (REs) can trigger innate immune responses via “viral mimicry”, imposing selective immune pressure on emerging tumor cells. We propose that RE mimics mediate transitions from initial anti-tumorigenic immune selection to a tolerized equilibrium shaped by trade-offs that can ultimately be predicted and exploited therapeutically.
Sun et al. (Fri,) studied this question.